Loading...

argenx SE

ARGXNASDAQ
Healthcare
Biotechnology
$663.18
$2.21(0.33%)

argenx SE (ARGX) Stock Competitors & Peer Comparison

See (ARGX) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ARGX$663.18+0.33%40.6B33.79$19.64N/A
VRTX$397.38+0.77%101.9B28.25$14.07N/A
REGN$591.93+0.16%62.3B15.09$39.66+0.44%
ALNY$458.16-0.03%61.3B-189.29-$2.47N/A
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
BNTX$111.50+0.18%26.6B-66.33-$1.67N/A
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
SMMT$26.73+3.30%19.3B-25.75-$1.01N/A
DNA-WT$0.27-2.76%18.7BN/AN/AN/A
INCY$85.58-0.72%16.9B20.46$4.23N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ARGX vs VRTX Comparison August 2025

ARGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARGX stands at 40.6B. In comparison, VRTX has a market cap of 101.9B. Regarding current trading prices, ARGX is priced at $663.18, while VRTX trades at $397.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARGX currently has a P/E ratio of 33.79, whereas VRTX's P/E ratio is 28.25. In terms of profitability, ARGX's ROE is +0.26%, compared to VRTX's ROE of +0.22%. Regarding short-term risk, ARGX is less volatile compared to VRTX. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.Check VRTX's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;